Life-saving antiretroviral medicines (ARVs) are vital for HIV programs and account for nearly 40 percent of the Global Fund’s Pooled Procurement Mechanism annual spend. Our Market Shaping Strategy and our position as one of the largest global buyers of ARVs guide our commitment to facilitating healthy, balanced and sustainable markets.
We collaborate with implementing partners and other large buyers to consolidate information, understand the demand landscape and share improved forecasts. Working with partners through the multiagency ARV Procurement Working Group allows us to coordinate order cycles and promote optimal products. Quality-assured ARVs and other medicines used in HIV programs are available through the Pooled Procurement Mechanism on our online purchasing platform, wambo.org. We publish current reference prices and the Procurement and Delivery Planning Guide with up-to-date indicative lead times:
We continuously refine our sourcing and procurement strategy to ensure Global Fund-supported programs receive the best value for money. In July 2018, we signed new framework agreements with suppliers following a competitive tender process. By promoting the introduction of newer, more effective and less expensive HIV medicines, we achieved lower prices, a more diverse supplier base and improved market visibility. Between 2018 and 2021, we anticipate savings of over US$300 million.
Supplier performance management underpins our approach, and suppliers are required to adhere to the Global Fund Code of Conduct for Suppliers and Quality Assurance Policies. We allocate volume annually and monitor production planning, responsiveness and on-time-in-full delivery performance to mitigate supply risks and increase market visibility.
Documents related to our strategy, past tenders and reference prices are available for download here.
Our Market Shaping Strategy directs the Global Fund to "secure the pediatric ARV market" by adopting a coordinated approach to the procurement of pediatric ARVs in the fight against HIV/AIDS. The ARV Procurement Working Group was established in September 2011 with a focus on the procurement of pediatric ARVs, and has evolved its scope to include ARVs for adolescents and adults. It is comprised of diverse partners and stakeholders who support the collective efforts toward securing the ARV market. The Global Fund chairs the group.
More information about the ARV Procurement Working Group is on its website. Documents are available here for download.